AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (March 20, 2003). doi:10.1152/ajpheart.00956.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/H97    most recent
00956.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, Q.
Right arrow Articles by Hofmann, P. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, Q.
Right arrow Articles by Hofmann, P. A
Submitted on November 5, 2002
Accepted on March 14, 2003

Modulation of protein phosphatase 2a by adenosine A1 receptors in cardiomyocytes: Role for p38 MAPK

Qinghang Liu1 and Polly A Hofmann1*

1 Department of Physiology, University of Tennessee Health Science Center, Memphis, TN, USA

* To whom correspondence should be addressed. E-mail: phofmann{at}physio1.utmem.edu.

Adenosine A1 receptor activation causes protein phosphatase 2a (PP2a) activation in ventricular myocytes. This attenuates beta-adrenergic functional effects in the heart (Liu and Hofmann, Am J Physiol 283: H1314-21, 2002). The purpose of the present study was to identify the signaling pathway involved in the translocation/activation of PP2a by adenosine A1 receptors in ventricular myocytes. We found N6-cyclopentyladenosine (CPA; adenosine A1 receptor agonist)-induced PP2a translocation was blocked by p38 MAPK inhibition, but not by JNK inhibition. CPA increased phosphorylation of p38 MAPK and this effect was abolished by pertussis toxin and inhibitors of the cyclic GMP pathway. Moreover, CPA-induced PP2a translocation was blocked by inhibition of the cyclic GMP pathway. Guanylyl cyclase activation mimicked the effects of CPA and caused p38 MAPK phosphorylation and PP2a translocation. Finally, CPA-induced dephosphorylations of troponin I and phospholamban were blocked by pertussis toxin and attenuated by p38 MAPK inhibition. These results suggest adenosine A1 receptor-mediated PP2a activation uses a pertussis toxin sensitive Gi protein-guanylyl cyclase-p38 MAPK pathway. This proposed, novel pathway may play a role in acute modulation of cardiac function.




This article has been cited by other articles:


Home page
CirculationHome page
I. Szokodi, R. Kerkela, A.-M. Kubin, B. Sarman, S. Pikkarainen, A. Konyi, I. G. Horvath, L. Papp, M. Toth, R. Skoumal, et al.
Functionally Opposing Roles of Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase in the Regulation of Cardiac Contractility
Circulation, October 14, 2008; 118(16): 1651 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. J. Leary, S. Rajasekaran, R. R. Morrison, E. I. Tuomanen, T. K. Chin, and P. A. Hofmann
A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2775 - H2784.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. R. Junttila, S.-P. Li, and J. Westermarck
Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival
FASEB J, April 1, 2008; 22(4): 954 - 965.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Ballard-Croft, A. C. Locklar, B. J. Keith, R. M. Mentzer Jr, and R. D. Lasley
Oxidative stress and adenosine A1 receptor activation differentially modulate subcellular cardiomyocyte MAPKs
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H263 - H271.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. A. Hofmann, M. Israel, Y. Koseki, J. Laskin, J. Gray, A. Janik, T. W. Sweatman, and L. Lothstein
N-Benzyladriamycin-14-valerate (AD 198): A Non-Cardiotoxic Anthracycline That Is Cardioprotective through PKC-{epsilon} Activation
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 658 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Cheng, J. Liu, M. Asuncion-Chin, E. Blaskova, J. P. Bannister, A. M. Dopico, and J. H. Jaggar
A Novel CaV1.2 N Terminus Expressed in Smooth Muscle Cells of Resistance Size Arteries Modifies Channel Regulation by Auxiliary Subunits
J. Biol. Chem., October 5, 2007; 282(40): 29211 - 29221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. A. Sheehan, Y. Ke, and R. J. Solaro
p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R963 - R973.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
M. E. Reichelt, L. Willems, J. N. Peart, K. J. Ashton, G. P. Matherne, M. R. Blackburn, and J. P. Headrick
Heart/Cardiac Muscle: Modulation of ischaemic contracture in mouse hearts: a 'supraphysiological' response to adenosine
Exp Physiol, January 1, 2007; 92(1): 175 - 185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Y. Tan, C. L. Richard, H. Zhang, D. W. Hoskin, and J. Blay
Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway
Am J Physiol Cell Physiol, September 1, 2006; 291(3): C433 - C444.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Snabaitis, R. D'Mello, S. Dashnyam, and M. Avkiran
A Novel Role for Protein Phosphatase 2A in Receptor-mediated Regulation of the Cardiac Sarcolemmal Na+/H+ Exchanger NHE1
J. Biol. Chem., July 21, 2006; 281(29): 20252 - 20262.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. I. Tikh, R. A. Fenton, and J. G. Dobson Jr.
Contractile effects of adenosine A1 and A2A receptors in isolated murine hearts
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H348 - H356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. D. Lasley, B. J. Keith, G. Kristo, Y. Yoshimura, and R. M. Mentzer Jr.
Delayed adenosine A1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H785 - H791.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. S. Gigena, A. Ito, H. Nojima, and T. B. Rogers
A B56 regulatory subunit of protein phosphatase 2A localizes to nuclear speckles in cardiomyocytes
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H285 - H294.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Ballard-Croft, G. Kristo, Y. Yoshimura, E. Reid, B. J. Keith, R. M. Mentzer Jr., and R. D. Lasley
Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1359 - H1366.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Hersch, J. Huang, J. R. Grider, and K. S. Murthy
Gq/G13 signaling by ET-1 in smooth muscle: MYPT1 phosphorylation via ETA and CPI-17 dephosphorylation via ETB
Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1209 - C1218.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Liu and P. A. Hofmann
Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2204 - H2212.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Schulz and G. Heusch
Connexin 43 and ischemic preconditioning
Cardiovasc Res, May 1, 2004; 62(2): 335 - 344.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. M. Metzger and M. V. Westfall
Covalent and Noncovalent Modification of Thin Filament Action: The Essential Role of Troponin in Cardiac Muscle Regulation
Circ. Res., February 6, 2004; 94(2): 146 - 158.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.